Among the many mysteries about long COVID, one of the most vexing has been why women seem to experience the condition more often and more severely than men. Now, scientists
In 2018, World Athletics insisted Semenya's natural testosterone levels were too high for her to compete as a woman. Now, that arbitrary measure could change.
GSK plc (LSE/NYSE: GSK) today announced new 48-week data from the MOMENTUM phase III trial that showed a majority of patients treated with investigational momelotinib maintained their responses across key clinical measures including Total Symptom Score (TSS), Transfusion Independence (TI) rate, and Splenic Response Rate (SRR) in myelofibrosis patie